Cambridge, Massachusetts, United States Qiming Venture Partners USA is the famous VC, which was founded in 2006.
The overall number of key employees were 12.
The usual cause for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Surveyor Capital, Sanofi, NanoDimension. In the next rounds fund is usually obtained by Roche Venture Fund.
Among the various public portfolio startups of the fund, we may underline Icosavax Among the most popular fund investment industries, there are Health Care, Biotechnology. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
The fund is generally included in 2-6 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2019.
Related Funds
Funds with similar focus
| Fund Name | Location |
| 313 Ventures | Detroit, Michigan, United States |
| Ammann Group | Bern, Langenthal, Switzerland |
| Banque Populaire Atlantique | - |
| Barinboim Investment | - |
| Brazilian Ministry of Health | Brasília, Brazil, Rio Grande do Norte |
| Cherry Creek Holdings | - |
| Cloud Ventures | China, Guangdong, Shenzhen |
| Enlight Ventures | - |
| H20 Capital | - |
| Honeycomb Investment Trust | England, London, United Kingdom |
| KAIST Venture | - |
| Meltwind Advisory | Cambridge, Cambridgeshire, United Kingdom |
| MTGx | Stockholm, Stockholm County, Sweden |
| Neogen.biz | - |
| OneSpan | Chicago, Illinois, United States |
| Prescott General Partners | - |
| Safestone Technologies Ltd | England, Sheffield, United Kingdom |
| Venus MedTech | China, Hangzhou, Zhejiang |
| Xenon Ventures | Beaverton, Oregon, United States |
| YungPark Capital | China, Shanghai |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Tenpoint Therapeutics | $70M | 12 Jul 2023 | Cornwall, England, United Kingdom | ||
Abdera Therapeutics | $142M | 20 Apr 2023 | Vancouver, British Columbia, Canada | ||
Entact Bio | $81M | 06 Dec 2022 | Watertown, Massachusetts, United States | ||
Soda Health | $25M | 13 Sep 2022 | - | ||
Auron Therapeutics | $48M | 20 Jul 2022 | Massachusetts, United States | ||
Boulder Care | $36M | 10 Jun 2022 | Portland, Oregon, United States | ||
Korro Bio | $116M | 05 Jan 2022 | Cambridge, Massachusetts, United States | ||
Ventyx Biosciences | $51M | 20 Sep 2021 | Encinitas, California, United States | ||
Soda Health | $6M | 19 Aug 2021 | - |
– HilleVax, Inc. (HilleVax), a biopharmaceutical company focused on the development and commercialization of novel vaccine candidates, announced the close of a $135 million crossover financing led by Frazier Healthcare Partners and joined by RA Capital Management, Deerfield Management Company, Abingworth, Lightspeed Venture Partners, Perceptive Advisors, Catalys Pacific, Samsara BioCapital, BVF Partners, Qiming Venture Partners USA, Greenspring Associates, Richard King Mellon Foundation, and Sahsen Ventures.
– The proceeds of this financing support the further clinical development of HilleVax’s virus-like particle (VLP) based vaccine candidate, HIL-214, for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.
– Soda Health from Bentonville is a healthcare technology company.
– The company raised $6m in seed funding.
– The round was led by Lightspeed Venture Partners and Define Ventures with participation from Qiming Venture Partners USA.
– The new investment will be used to expand operations and business reach.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Tenpoint Therapeutics | $70M | 12 Jul 2023 | Cornwall, England, United Kingdom | ||
Abdera Therapeutics | $142M | 20 Apr 2023 | Vancouver, British Columbia, Canada | ||
Entact Bio | $81M | 06 Dec 2022 | Watertown, Massachusetts, United States | ||
Soda Health | $25M | 13 Sep 2022 | - | ||
Auron Therapeutics | $48M | 20 Jul 2022 | Massachusetts, United States | ||
Boulder Care | $36M | 10 Jun 2022 | Portland, Oregon, United States | ||
Korro Bio | $116M | 05 Jan 2022 | Cambridge, Massachusetts, United States | ||
Ventyx Biosciences | $51M | 20 Sep 2021 | Encinitas, California, United States | ||
Soda Health | $6M | 19 Aug 2021 | - |
